Literature DB >> 11877312

Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia.

Lucia D Notarangelo1, Cinzia Mazza, Silvia Giliani, Chiara D'Aria, Francesca Gandellini, Chiara Ravelli, Maria Grazia Locatelli, David L Nelson, Hans D Ochs, Luigi D Notarangelo.   

Abstract

Mutations of the WASP gene have been previously shown to be responsible for classical Wiskott-Aldrich syndrome, isolated X-linked thrombocytopenia, and severe, congenital X-linked neutropenia. We report herewith 2 families in which affected males had a history of intermittent thrombocytopenia with consistently reduced platelet volume, in the absence of other major clinical features, and carried missense mutations of the WASP gene that allowed substantial protein expression. This observation broadens the spectrum of clinical phenotypes associated with WASP gene defects, and it indicates the need for molecular analysis in males with reduced platelet volume, regardless of the platelet number.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11877312     DOI: 10.1182/blood.v99.6.2268

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  25 in total

Review 1.  The molecular pathology of primary immunodeficiencies.

Authors:  Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  J Mol Diagn       Date:  2004-05       Impact factor: 5.568

Review 2.  Wiskott-Aldrich syndrome: another piece in the puzzle.

Authors:  L D Notarangelo; L Mori
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

Review 3.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 4.  Hematopoietic cell transplantation for Wiskott-Aldrich syndrome: advances in biology and future directions for treatment.

Authors:  Sung-Yun Pai; Luigi D Notarangelo
Journal:  Immunol Allergy Clin North Am       Date:  2010-05       Impact factor: 3.479

Review 5.  Warts and all: human papillomavirus in primary immunodeficiencies.

Authors:  Jennifer W Leiding; Steven M Holland
Journal:  J Allergy Clin Immunol       Date:  2012-10-01       Impact factor: 10.793

6.  N-WASP is a putative tumour suppressor in breast cancer cells, in vitro and in vivo, and is associated with clinical outcome in patients with breast cancer.

Authors:  Tracey A Martin; Gordon Pereira; Gareth Watkins; Robert E Mansel; Wen G Jiang
Journal:  Clin Exp Metastasis       Date:  2007-11-06       Impact factor: 5.150

7.  Rapid platelet turnover in WASP(-) mice correlates with increased ex vivo phagocytosis of opsonized WASP(-) platelets.

Authors:  Amanda Prislovsky; Bindumadhav Marathe; Amira Hosni; Alyssa L Bolen; Falk Nimmerjahn; Carl W Jackson; Darryl Weiman; Ted S Strom
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

Review 8.  The thrombocytopenia of WAS: a familial form of ITP?

Authors:  Ted S Strom
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 9.  Mutations of the Wiskott-Aldrich Syndrome Protein affect protein expression and dictate the clinical phenotypes.

Authors:  Hans D Ochs
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Antiplatelet antibodies in WASP(-) mice correlate with evidence of increased in vivo platelet consumption.

Authors:  Bindumadhav M Marathe; Amanda Prislovsky; Alexander Astrakhan; David J Rawlings; Jim Y Wan; Ted S Strom
Journal:  Exp Hematol       Date:  2009-09-03       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.